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a,-Antitrypsin (AT) is the principal serum inhibitor of proteolytic enzymes such as neutrophil elastase. AT can exist 
as over 90 different genetically determined variants known as the Pi system; the three most important variants are 
type M (90% of population) and types S and Z, two of the commoner abnormal variants. Homozygotes of type Z 
have a severe reduction in the serum AT concentration and may develop pulmonary emphysema or hepatic cirrhosis. 
Heterozygotes of type SZ have a less severe reduction in serum AT concentration and the association with clinical 
disease is less clear. 
The S and Z variants are found mainly among those of European stock. The gene frequency for Pi type Z is 
highest on the north-western seaboard of the continent and the mutation seems likely to have arisen in southern 
Scandinavia. The distribution of type S is quite different; the gene frequency is highest in the Iberian peninsula and 
the mutation is likely to have arisen in that region. A population survey for determining the number of type Z 
homozygotes in a given community is important for planning purposes now that AT replacement therapy is 
potentially available. 
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Introduction 
a,-Antitrypsin (AT) deficiency is a genetic disorder pre- 
dominantly arising in those of European stock. AT is the 
main serum inhibitor of proteolytic enzymes and it is 
believed that, in AT deficiency, enzymes such as neutrophil 
elastase can damage the lung tissues leading to the disabling 
syndrome of pulmonary emphysema. The original cases 
were recognized by Swedish workers (1,2) and their descrip- 
tion of the clinical features has been confirmed on many 
occasions (3-S). An association between AT deficiency and 
neonatal hepatitis was first described by Sharp et al. (6) and 
there is a risk of cirrhosis in adult life (7). This is thought to 
be due to the presence of inclusion bodies of AT deposited 
within the hepatocytes. 
The term AT was introduced by the original discoverers 
of the condition, but it is now recognized that the main 
function of the protein is the inhibition of neutrophil 
elastase. Terms such as a,-proteinase inhibitor or 
a,-antiproteinase have been introduced as a more accurate 
functional description but the more familiar name AT will 
be used in this article. 
AT deficiency has been reported in virtually every 
country in Europe but it now seems to have been no 
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accident that the initial discovery was made in Sweden; 
Eriksson in a recent historical review of this period (8) has 
reminded us of the long Swedish tradition of research in 
protein chemistry and particularly in protein separation 
techniques. The method of paper electrophoresis was much 
improved by Laurell; the absence of the protein band in the 
a, region of type Z homozygotes was first detected by this 
method (1) and shown to be associated with pulmonary 
emphysema. 
Methods 
New advances in the methodology soon indicated that AT 
is a polymorphic system with a large number of possible 
biochemical variants (the Pi system). This was first demon- 
strated independently, again in Scandinavia, by two groups 
of workers (9,lO) using the method of starch gel electro- 
phoresis (SG). A problem with this otherwise very useful 
technique was the difficulty in recognizing the Z bands due 
to the small quantity of AT actually reaching the serum. 
This particularly affected the recognition of the MZ hetero- 
zygote where the M bands could appear normal while the Z 
bands went undetected. With the homozygous deficiency 
(Pi type ZZ) the difficulty did not usually arise as one 
could readily deduce the probable phenotype from the 
total absence of M bands and if necessary this could 
be confirmed by direct measurement of the serum AT 
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concentration by an immunological method. The rarity of 
the Z homozygote means, however, that gene frequencies 
must be calculated almost entirely from the frequency of 
the MZ heterozygote which may be significantly under- 
estimated by the SG method. 
To overcome this problem the method of ‘crossed 
antigen-antibody electrophoresis’ (XAA) was introduced 
(11). The individual starch gel is cut out and run again at 
right angles into the medium containing the antibody. 
Prevalence studies in which SG was used alone (without 
XAA) have generally given lower frequencies for Pi type Z 
than those which include XAA; the combined method has 
usually given results consistent with modern techniques. 
XAA was time consuming and expensive and has 
been replaced by the technique of isoelectric focusing in 
polyacrylamide gels (IEF) (12-14). 
The bands associated with Pi type S are usually much 
more readily detectable than those of type Z even with SG 
alone and the gene frequency results obtained by the 
various techniques are more consistent. Since the 
introduction of IEF, over 90 variants have been 
recognized (15) although most are very rare and few are of 
clinical importance. There are five or more subtypes of the 
common M variant which have allowed the method 
to be widely used in parentage testing and in forensic 
investigations. 
The conditions of sample storage are also of importance 
and it has been observed that the specific bands may be 
seriously weakened if the specimens are subjected to 
repeated freezing and thawing. A false FM pattern can be 
generated from type M in aged samples or if storage 
conditions have been unsatisfactory (16). In liver disease, a 
false SZ pattern may be seen in homozygotes of type Z (17). 
For further details of the methodology the reader is referred 
to more detailed reviews (16,18). 
DRIED BLOOD SPOT METHOD 
Dried blood samples collected on filter paper have been 
used as a convenient method of screening newborn infants 
(19). After elution, the sample phenotypes are assessed by 
IEF. Again, the storage conditions are important if valid 
results are to be obtained. 
Alternatively, the serum AT concentration can be 
obtained from the eluate by an immunological method (20). 
It is then necessary to choose a cut-off value below which 
the majority of severely deficient sera (e.g. type ZZ) are 
likely to fall. A fresh blood sample is then obtained for 
those falling into the deficient range. By this method few of 
the MS or MZ heterozygotes will be detected and gene 
frequencies therefore cannot be calculated. 
DNA-BASED ASSAYS 
Methods of DNA analysis utilizing the polymerase chain 
reaction have been developed which allow detection of the 
S and Z mutations (21,22). These methods have not yet 
been reported in population surveys. 
Prevalence Surveys 
Almost all prevalence surveys in Europe since about 
1976 have been performed by the method of IEF and 
the available results, together with some earlier results 
obtained by SG and XAA (but not reports of type Z 
obtained by SG alone), are included in Table 1. Certain 
laboratories have introduced their own variations on the 
IEF technique depending on the precise purpose of 
the survey; for instance, a method which is optimal for 
separating the M subtypes may be less than optimal 
for detecting the more slowly moving variants such 
as types S and Z. These methods will not be discussed in 
detail here. 
Patients homozygous for Pi type Z are the most com- 
monly encountered form of severe AT deficiency associated 
with emphysema. One purpose of a population survey is to 
detect Pi ZZ patients at risk of developing emphysema and 
to determine their total number in a given community. This 
is particularly important as specific replacement therapy is 
potentially available (83) although its effectiveness is not yet 
known. 
Gene Frequency 
The prevalence of the various gene types in any popula- 
tion is best expressed as the ‘gene frequency’ which can 
be defined as the frequency of all genes of a particular 
type whether occurring in homozygotes or heterozygotes. 
Thus type MZ individuals contribute one Z gene to the 
total whereas type ZZ individuals contribute two. It can 
be shown by the ‘Hardy-Weinberg’ principle (84) that 
the prevalence of the type Z homozygote is equal to 
the square of the gene frequency for that allele. For 
example, in Southern Sweden (Table l), where the 
gene frequency for type Z is quoted as 0.0231 or 23.1 per 
1000, the calculated ZZ homozygote prevalence is 
0.00053 or 1 in 1870. By contrast, in Northern Sweden, 
the gene frequency for type Z is 8.3 per 1000 and the 
calculated ZZ homozygote prevalence is therefore only 
1 in 14 500. 
The gene frequency for type Z is determined almost 
entirely by the prevalence of the heterozygous subjects, 
mainly MZ, who carry over 95% of the type Z genetic 
material. Any error in the gene frequency estimate will 
therefore be greatly magnified when the prevalence of the 
homozygote is calculated. Pi type S is also a deficient 
phenotype especially when combined in the heterozygous 
form SZ where the serum AT concentration is usually 
3040% of normal. Even so, this phenotype appears to 
predispose to emphysema only in smokers (85). Type S is 
the commonest of the non-M variants and it is clearly 
important to assess its frequency in any survey. The preva- 
lence of the SZ phenotype can also be calculated from the 
Hardy-Weinburg principle, as twice the product of the 
respective gene frequencies for types S and Z; again, errors 
in the gene frequency estimates will be much magnified in 
this calculation. 
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TABLE 1. Gene frequencies in Europe 
Country 
Subjects Gene frequency* 
No. Source S Z Method Reference 
Northern Europe 
Norway 
Oslo & Stavanger 
Oslo 
Sweden 
South 
North 
Umea (North) 
Finland 
Non-Lapps 
Helsinki 
Helsinki 
Oulu 
Lamps 
Finnish 
Norwegian 
Swedish 
Denmark 
Iceland 
Western Europe 
Netherlands 
Industrial town 
NE rural 
United Kingdom 
N Ireland 
SW England 
London 
England 
Scotland 
NW England 
France 
Normandy 
Normandy 
Brittany 
(Morbihan) 
(Bigoudens) 
(Non-Bigoud) 
Lyon 
East 
Nancy 
North 
Rouen 
Paris-Clichy 
Paris-Creteil 
Paris-Villejuif 
South-west 
Toulouse 
Bordeaux 
South 
Marseille 
390 BD 17.9 - SG 
2830 BD PG 23.0 15.7 XAA 
400 BD Pat 30.0 18.8 IEF 
(10) 
(23) 
(24) 
1062 Pat 24.5 23.1 IEF (25) 
1869 AMY 10.4 8.3 IEF (26) 
619 POP 12.1 10.5 IEF (27) 
223 Pop Lab 0 
136 POP 0 
548 BD 17.3 
300 Army 15.0 
200 NB 11.5 
4.5 XAA (28) 
10.0 IEF (2% 
13.7 IEF (30) 
13.0 IEF (26) 
5.0 IEF (31) 
468 POP 
302 POP 
217 Stud 
909 Pat PG 
94 POP 
3.2 1.1 XAA (28) 
0 8.3 XAA (28) 
4.6 0 IEF (26) 
22.0 22.6 IEF (32) 
10.6 0 XAA (33) 
672 POP 
802 POP 
708 BD 
131 Lab PG 
357 POP 
24.6 17.9 IEF (34) 
8.8 7.4 IEF (34) 
29.7 4.9 IEF (35) 
42 27 IEF (29) 
29.4 12.6 IEF (36) 
1995 Workers 42.4 
926 BD 41.5 
2310 Pat 46.3 
3174 Bl samp 45.5 
1291 Bl samp 45.7 
316 BD Pat Pop 52.2 
20.8 XAA (37) 
22.1 IEF (38) 
18.2 IEF (39 
- SG (40) 
- SG (40) 
9.5 IEF (41) 
394 BD 
1030 BD 
66 22 XAA 
63.1 17.9 XAA 
(42) 
(43) 
280 BD 
397 Pop 
100 Pop 
1653 BD 
75.0 23.2 XAA (44) 
63.0 16.4 IEF (45) 
60.0 5.0 IEF (45) 
71.3 14.2 IEF (46) 
1551 Workers 51.9 11.0 IEF 
419 Workers 
371 Workers 
151 Workers 
719 Workers 
68.0 7.2 IEF 
90.3 6.7 IEF 
76.2 13.2 IEF 
84.1 11.1 IEF 
1247 Workers 
356 Workers 
105.0 12.8 IEF 
125.0 22.5 IEF 
239 Workers 37.6 4.2 IEF 
(47) 
(47) 
(47) 
(47) 
(47) 
(47) 
(47) 
(47) 
370 TOPICAL REVIEWS 
TABLE 1. Continued 
Country 
Subjects Gene frequency* 
No. Source S Z Method Reference 
Western Europe 
Belgium 
Spain 
Madrid 
Madrid 
Seville 
Galicia 
Galicia 
Basque region 
Native (Arratia) 
Native 
Other Basque 
Other Basque 
Portugal 
Lisbon 
Lisbon 
All regions 
Central Europe 
Germany 
Hamburg 
Marburg 
Munich 
Munich 
Hessen 
South 
South 
Austria 
Tyrol 
Switzerland 
Zurich 
Southern Europe 
Italy 
S Tyrol 
Italian 
German 
Turin 
Cuneo 
Parma 
Verona 
Bologna 
Genoa 
Livorno 
Grosset0 
Arrezzo 
Perugia 
Spoleto 
Rome 
Rome 
Rome 
Campobasso 
Naples 
1345 NB 54.3 16.7 IEF (48) 
378 
103 
170 
131 
129 
480 
146 
56 
167 
810 
176 
Hosp 
Pop 
Pop 
Pop 
Pop 
Pop 
BD 
Pop 
BD 
Pop 
112 11.9 XAA (49) 
82.5 0 IEF (50) 
97.1 0 XAA (51) 
99.3 11.4 XAA (51) 
147 3.9 XAA (51) 
149 9.4 IEF (52) 
116 6.9 XAA (51) 
107 0 IEF (53) 
99 0 IEF (54) 
116 7 IEF (53) 
88 17 IEF (54) 
39 Seamen 141 0 XAA (49) 
330 Pop 115.2 18.2 XAA (55) 
219 Stud 54.8 22.8 XAA (56) 
900 pop 152 10 IEF (57) 
516 Pop 21.3 8.7 XAA (33) 
262 pop 22.9 9.5 XAA (58) 
146 Pat 34.2 13.7 IEF (59) 
538 BD Lab 22.3 12.1 IEF (60) 
280 Workers 30 14 IEF (61) 
229 BD 24.0 10.9 IEF (62) 
357 Pat 23.0 18.7 IEF (63) 
752 Pat 17.3 12.7 IEF (64) 
868 BD 22.5 13.8 IEF (65) 
1148 Pat 38.3 11.3 IEF (66) 
1606 NB 31.8 15.0 IEF (67) 
7522 NB 14.6 19.5 IEF (67) 
394 BD NB 31.8 8.3 IEF (68) 
208 BD NB 55.0 4.7 IEF (68) 
268 BD NB 24.7 13.3 IEF (68) 
202 Hosp 29.7 9.9 IEF (69) 
263 BD NB 14.0 8.5 IEF (68) 
389 BD 33.9 10.2 IEF (70) 
490 BD NB 29.6 7.1 IEF (68) 
172 BD NB 17.8 2.9 IEF (68) 
472 NB 36.0 5.2 IEF (70) 
100 BD NB 27.4 0 IEF (68) 
120 BD NB 42.7 8.5 IEF (68) 
500 NB 67.0 15.0 IEF (71) 
967 NB 43.9 10.8 IEF (70) 
513 BD 28.3 9.7 IEF (72) 
600 BD NB 26.9 3.0 IEF (68) 
260 NB 25.0 11.6 IEF (73) 
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TABLE 1. Continued 
Country 
Subjects Gene frequency* 
No. Source S Z Method Reference 
Southern Europe 
Italy 
Sicily 
Palermo 
Sardinia 
Cagliari 
Cagliari 
Serbia 
Greece 
Nine regions 
Athens 
175 BD NB 16.3 8.1 IEF (68) 
100 BD NB 62.5 0 
218 BD 61.9 4.6 
1060 BD 6.6 12.7 
IEF 
IEF 
IEF 
(68) 
(74) 
(75) 
400 Pop 
504 Pop 
160 Hosp 
2.5 16.2 XAA 
28 2 XAA 
3.1 6.2 IEF 
(33) 
(76) 
(77) 
Eastern Europe 
Hungary 
Twelve groups 
Poland 
Poznan 
172 Pop 
1282 Pop 
17.4 14.5 XAA 
14.0 6.0 IEF 
(33) 
(78) 
3560 BD 15.6 
631 BD Pop 14.2 
SG 
IEF 
(79) 
(W 
- 
15.0 
Russia 
Moscow 
Kalinin 
402 Pop 
1049 Pop 
6.2 4.8 IEF 
16.5 3.2 IEF 
(81) 
WI 
BD, blood donors; NB, newborns; Pat, parentage tests; PG, pregnant women; Lab, laboratory or 
hospital staff, Stud, school or college students; Hosp, hospital patients; Bl samp, blood samples; Pop, 
population register, electoral roll, randomly selected, healthy or unrelated subjects; Workers, 
employees or workplace survey; SG, starch gel; XAA, crossed antigen-antibody electrophoresis; 
IEF, isoelectric focusing. *Gene frequency: per 1000. 
subjects involved in parentage disputes and subjects 
obtained from a population register or electoral roll; in 
some surveys, the subjects are described as ‘randomly 
selected’ or ‘unrelated’, although the details of the selection 
procedures are often not given in detail. 
The S and Z Phenotypes Analysed by 
Country and Region 
All European population surveys known to the author have 
been quoted (Table 1) provided that the subjects appear to 
represent a randomly selected ‘normal’ group and that Pi 
type was determined in all subjects by IEF or by XAA. In 
surveys where SG was used alone (as in many of the early 
studies) the gene frequencies for type Z have been omitted 
from Table 1, as they may be underestimated by this 
method. Surveys in which subjects with abnormal pheno- 
types such as SZ or ZZ were identified only after an initial 
screening procedure have also been omitted as true gene 
frequencies cannot be calculated under these circumstances. 
The district or origin of the subjects is given if specified by 
the authors. 
SAMPLE SIZE 
The sample size in the various surveys (Table 1) ranges 
from 39 to 7522 subjects, although in over half of the 
surveys the number of subjects lies between 100 and 500. 
The total numbers available in small isolated communities 
(which are potentially of great interest) may be quite 
limited, increasing the possibility of error in the estimate of 
gene frequency. 
The 95% confidence limits for three allele population 
sizes at three typical gene frequencies are given in Table 2. 
The confidence limits are wide especially when gene fre- 
quency is low, and it follows that, in any population 
sample, the number of subjects (half the number of alleles) 
should ideally be 250 or more. 
SELECTION OF SUBJECTS 
A wide range of subjects have been chosen for study 
in the various surveys. They include blood donors, army 
conscripts, seamen, laboratory or hospital staff, pregnant 
women, work-based employees, students, newborn infants, 
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TABLE 2. Confidence limits (95%) at various gene 
frequencies and population sizes 
Gene No. of 
frequency alleles 
95% 
confidence limits 
100 1000 82-120 
500 75-l 30 
200 62-l 50 
20 1000 12-31 
500 lo-37 
200 5-50 
10 1000 5-18 
500 3-23 
200 l-36 
Gene frequencies and confidence limits (86) expressed per 
1000 alleles. 
If the gene frequencies are not given by the authors, they 
have been calculated from the quoted phenotype fre- 
quencies. The gene frequency is obtained in the standard 
manner by summing the total number of alleles in question 
(Pi type Z, for instance) and expressing this number as a 
fraction of the total number of Pi type alleles in the 
population; the total number of alleles is of course twice the 
number of subjects. For ease of comparison, all gene 
(a: 
frequencies have been expressed per 1000 genes; thus, in the 
first line of Table 1, the gene frequency for Pi type S 
in Norway is given as 17.9 per 1000 instead of the 
conventional 0.0179. 
Distribution of Gene Frequencies for Pi 
Types S and Z (Fig. 1) 
PI TYPE S 
The distribution of the type S gene within Europe is shown 
in Fig. l(a). The value declines from east to west over the 
whole continent, ranging from <20 per 1000 in the east to 
>90 in the Iberian peninsula. A similar high figure is found 
among the Basque community although they are regarded 
as an unusual population from the genetic point of view as 
discussed below. The high gene frequency suggests that the 
S mutation may have arisen in the north of the Iberian 
peninsula in prehistoric times and spread eastwards by 
large-scale population movements, the process known as 
‘gene flow’. A very low type S frequency on the other hand 
is seen in the isolated Lapp community. 
The distribution of the deficient heterozygous phenotype 
SZ is dominated by the high gene frequency for type S and 
shows a similar decrease from west to east. The highest 
calculated figure is obtained in Portugal (about 1 in 330) 
falling to about 1 in 5000 in eastern Europe. 
(b: 1 
FIG. 1. Distribution (a) of Pi type S and (b) of Pi type Z in Europe. The gene frequency is expressed as the total number 
of Z or S genes (whether in homo- or heterozygotes) per 1000 genes of all Pi types. Shaded lines: ‘isogenes’ or lines of 
equal gene frequency (drawn by eye). The distribution of the two genes differs markedly; the greatest frequency of type Z 
is on the north-western seaboard of the continent whereas that of type S is greatest in the Iberian peninsula. Considering 
the isogenes for type Z, the gene frequencies of 15 per 1000 and 5 per 1000 are equivalent to homozygous ZZ prevalences 
of, respectively, 1 in 4440 and 1 in 40 000. (Political boundaries are inserted for guidance only.) Reproduced (with modifi- 
cation) from Respiratory Medicine 2nd edition (Eds Brewis et al.) 1995. By courtesy of W. B. Saunders Co. Ltd. 
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PI TYPE Z 
The distribution of gene frequency for type Z [Fig. l(b)] 
differs markedly from that of type S. The frequency of type 
Z in most countries is much less than that of type S so the 
data are rather less firm but the striking feature of the map 
is the relatively high gene frequency on the north-western 
seaboard of the continent. The gene frequency is very low 
among the Lapp and Basque communities. As with type S, 
the gene frequency is lower in the eastern regions of the 
continent and from other surveys (87) both types are rare 
among non-Europeans. It has been suggested (88) that the 
Z mutation occurred 66 generations or about 2000 years 
ago. The most likely site of origin seems to have been 
southern Scandinavia from the high gene frequency in that 
area and the known migration patterns, exemplified by the 
Viking colonization of north-western Europe in the 9th to 
1 lth centuries AD. 
Special Points about Various Regions 
SCANDINAVIA AND THE LAPPS 
The first study of AT phenotype frequency in any part of 
the world was reported from Norway using the newly 
developed technique of starch gel electrophoresis (10) and 
Norwegian and Finnish Lapps were studied by this method 
at an early stage (28). The Lapps are a population of great 
interest because of their evident isolation from other genetic 
influences. The gene frequencies for types S and Z in 
Finnish and Swedish Lapps are among the lowest recorded 
in Europe (26,28) although the figure for type Z (28) 
obtained in Norwegian Lapps was rather greater than 
among the other groups. 
There has been some speculation about the low preva- 
lence of type Z in this region; by one theory, genes 
predisposing to pulmonary disease could have been elimi- 
nated by the extreme climate of the northern winter. This 
theory assumes that heterozygotes for both Pi types S and Z 
have a similar susceptibility. The results appear more likely 
to be due to the fact that these culturally and linguistically 
separate peoples have remained as an ‘isolate’ and have 
never intermarried to any significant extent with those 
population groups bearing the S and Z mutations. 
Evidence from the distribution of the ABO blood groups 
among Lapps supports the latter viewpoint. The frequency 
of the A gene among Lapps and particularly of the sub-type 
A2 is much higher than in neighbouring regions (89) and 
the frequencies of many other blood group systems are also 
unusual; these authors observe that ‘in nearly all gene 
frequencies the Lapps differ widely from all other European 
populations’ and that this seems to be due to their long 
isolation as a small population. Analysis of genetic diver- 
gence from other European populations (based on 88 
genes) indicates that the Lapps are ‘extreme outliers’ 
followed in order by the Sardinians, Basques and 
Icelanders (90). 
The Swedish study of Sveger (91) in 200 000 newborn 
infants is the only survey large enough to enable a direct 
estimate of the prevalence of the ZZ homozygote to be 
obtained. One hundred and twenty type ZZ infants were 
detected giving a prevalence of 0.0006 or 1 in 1670 which is 
very close to the figure calculated from the gene frequency 
in the southern part of the country (25). 
ICELAND 
There has been only one survey (by XAA) among the 
Icelandic population (33). The gene frequency for type Z 
was found to be zero although the sample was small, 
consisting of only 94 subjects. In this study, however, the 
prevalence of Pi type F now appears to have been consid- 
erably overestimated (gene frequency: 117 per 1000) poss- 
ibly because of overlong storage which can generate false 
FM patterns from type M (16,40). Errors in estimates of the 
prevalence of types S and Z therefore seem possible. 
Historical records indicate that the original colonists emi- 
grated into Iceland during the 11th century mainly from 
Norway with a smaller group originating in Ireland. A 
survey of ABO blood groups, however, indicates a closer 
affinity to Ireland than to Norway (89). It would therefore 
be interesting to see the results of a survey by modern 
methods in this population. 
NETHERLANDS 
The results of surveys within a given country may differ 
considerably (34). In the industrial town of Vlaardingen, 
close to the great seaport of Rotterdam, the gene fre- 
quencies for both S and Z were similar to those of other 
nearby industrial areas. The same authors surveyed the 
small rural town of Vlagtwedde in the north-east of the 
country, with a population which ‘hardly ever moves 
outside of its birthplace’; they found very much lower 
gene frequencies for both alleles, suggesting a community 
relatively isolated from large population movements. 
FRANCE 
A large population of over 5000 employees in eight separate 
regions was studied by IEF as part of an epidemiological 
survey (47). The data together with those of other surveys 
indicate that the gene frequency for type S is substantially 
higher in south-western France and approaches that found 
in northern Spain. In the far south (Marseille), the gene 
frequencies for both types S and Z (47) were lower than in 
any other region of the country, possibly as a result of 
immigration into the area from Africa or Asia. 
The inhabitants of the Bigouden region in the west of 
Brittany have specific sociological patterns and have been 
the subject of special study (45); the gene frequencies for S 
and Z, however, do not differ from those of other Bretons. 
SPAIN, PORTUGAL AND THE BASQUE REGION 
A very high gene frequency for type S was noticed in 
an early study (49) among Spanish seamen calling at 
Norwegian ports. Some of the highest figures for type S in 
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Europe have been obtained in Portugal and in Galicia in 
north-western Spain; it seems likely that the S mutation 
occurred in this region at an unknown epoch. 
The Basque Region 
The inhabitants of the Basque region have aroused interest 
from the genetic point of view as they are considered to be 
a group who have largely remained isolated from their 
immediate neighbours until recent times (54). Their lan- 
guage, Euskera, is the only one spoken in western Europe, 
apart from the Lapp tongue, which does not belong to the 
Indo-European family. They have the lowest frequency for 
blood group B in Europe, O-3% in various surveys (51,89), 
and the highest for Rhesus group d (89). It has been 
suggested (90) that the Basques are the descendants of the 
late Paleolithic inhabitants of western Europe who were 
displaced by the neolithic peoples with high blood group B 
frequencies moving from the east. 
In two studies (53,54), the Pi types of subjects considered 
to be of pure Basque descent were examined. The gene 
frequencies for type S were at much the same high levels as 
found in other parts of Spain. For type Z, the gene 
frequency was found to be virtually zero in the pure Basque 
subjects. The gene frequency for type Z in Madrid was also 
found to be zero and is low in other regions of northern 
Spain. In spite of other marked genetic differences, the 
Pi type frequencies do not, in themselves, demonstrate 
any obvious differences between the Basques and their 
immediate neighbours. 
ITALY 
A large number of surveys have been reported from many 
regions and cities in Italy. Seventeen are quoted in one 
review (68) and a selection of these is given in Table 1. 
There is a wide range of frequencies particularly for type S. 
Weighted averages of the 17 surveys from mainland Italy 
(excluding the German Tyrol) with a total of 7524 subjects 
give gene frequencies of 34.6 per 1000 for type S and 10.0 
per 1000 for type Z. In a large survey of over 9000 subjects 
in the South Tyrol, there was an obvious difference between 
Italian and German speakers in the gene frequency for type 
S (67). 
In Sardinia, for subjects confirmed as being of local 
origin, the gene frequency for type S is much greater, and 
for type Z much smaller, than in most other regions of Italy 
(68,74). When other polymorphic systems are examined 
(blood groups or HLA types, for instance), Sardinia 
emerges. as genetically very far removed from all other 
Italian regions, including Sicily (90,92); the frequency of 
Rhesus group d is almost the lowest in Europe (89). 
GREECE 
Three studies (33,76,77) are available, the results of which 
differ considerably. Only the latest study was performed 
with IEF, giving a very low frequency for type S and an 
intermediate frequency for type Z. In terms of genetic 
divergence, the Greeks are regarded as among the ‘outliers’, 
although less extreme than the Lapps and Basques (90). A 
larger study of the Pi system among the Greeks would be of 
interest. 
HUNGARY 
In the more recent study (78) gene frequencies were 
obtained in 1282 subjects divided into 12 population 
groups. The overall gene frequencies are given in Table 1. 
Certain population groups had a significantly lower gene 
frequency for type S, firstly the Gipsies, thought to origi- 
nate in the Indian subcontinent, and secondly the J&z 
people, perhaps originating in China. 
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